MedTrace Logo

Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical Scanning

NCT00671385 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2011-02-01

No results posted yet for this study

Summary

The purposes of this study is to establish normal optical values of breast tissue in the general population. This will allow for establishing normals for breast composition, and is expected to be useful in the classification of breast lesions into groups such as cysts, benign growths, inflammatory lesions, and possibly early breast cancer.

Conditions

Sponsors & Collaborators

  • Stanford University

    collaborator OTHER

  • University of California

    collaborator OTHER

  • Palo Alto Medical Foundation

    collaborator OTHER

  • Spectros Corporation

    lead INDUSTRY

Principal Investigators

  • David A Benaron, MD · Spectros Corporation

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-04-30
Completion
2011-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00671385 on ClinicalTrials.gov